Select presentations made using PPMI data and specimens are cataloged here. Individuals making PPMI presentations who wish to share them through the website can contact us with information about the presentation for consideration for inclusion.
PPMI Presentations
| Title | Author(s) | Date | Meeting/Venue |
| 2018 PPMI Annual Investigators Meeting - Day 2 | 2018-05-03 | ||
| 2018 PPMI Annual Investigators Meeting - Day 1 | 2018-05-02 | ||
| Cell Line Resources from Parkinson's Progression Markers Initiative (PPMI) Participants | T. Ludwig, A. Reimer, T. Foroud, D. Smith, C. Wegel, C. Mitchell, R. Case, M. Frasier, A. Naito, S. Lasch, K. Marek, C. Dunifon | 2017-06-14 | ISSCR Conference, Boston |
| Early bilateral caudate involvement in Parkinson's disease is predictive of cognitive decline | Rory Durcan, Louise Wiblin, Morten Gersel Stokholm, Lynn Rochester, David J. Brooks1, David J. Burn, Nicola Pavese | 2017-06-06 | Vancouer |
| 2017 PPMI Annual Meeting - Day 2, Morning | 2017-05-04 | New York City | |
| 2017 PPMI Annual Meeting - Day 2, Afternoon | 2017-05-04 | New York City | |
| 2017 PPMI Annual Meeting - Day 1, Morning | 2017-05-03 | New York City | |
| 2017 PPMI Annual Meeting - Day 1, Afternoon | 2017-05-03 | New York City | |
| Structural Brain Alterations Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson's Disease | Soufiane Boucetta, Ali Salimi, Mahsa Dadar, Barbara E. Jones, D. Louis Collins & Thien Thanh Dang-Vu | 2016-06-01 | http://www.nature.com/articles/srep26782 |
| PPMI 2016 Annual Meeting presentations - Day 2 | 2016-05-04 | ||
| PPMI 2016 Annual Meeting presentations - Day 1 | 2016-05-04 | ||
| Improved Parkinson's Disease Classification from Diffusion MRI Data by Fisher Vector Descriptors | Salamanca, L.; Vlassis, N.; Diederich, N.; Bernard, F.; and Skupin A. | 2015-10-05 | Munich |
| Comparison Of Baseline 123?I Ioflupane SPECT Striatal Binding Ratios With Diffusion Tensor Images From The Parkinson's Progression Marker Initiative | Gallagher, C.L.; Sojkova, J; Bendlin, B.B.; Okonkwo, O; Alexander, A; Wu, I.W.; Schuff, N | 2015-06-14 | MDS: San Diego, CA |
| POSET Based Cognitive Function Impairment (PCFI): A Novel Approach For Delineating Heterogeneity Of Cognitive Impairment In Parkinson's Disease | Gupta, D.K.; Goldman, J.G.; Jaeger, J; Tatsuoka, C | 2015-06-14 | MDS: San Diego, CA |
| Novel Recruitment Strategy To Enrich For LRRK2 Mutation Carriers | Foroud, T; Smith, D; Jackson, J; Verbrugge, J; Halter, C; Wetherill, L; Sims, K; Xin, W; Arnedo, V; Lasch, S; Marek, K | 2015-06-14 | MDS: San Diego, CA |
| Incident Impulse Control Disorder Behaviors and Serial Dopamine Transporter Imaging in De Novo Parkinson Disease (Presentation) | Smith, K; Xie, S; Weintraub, D | 2015-06-14 | MDS: San Diego, CA |
| Olfaction And Nonmotor Symptoms (NMS) In Subjects With Scans Without Evidence Of Dopaminergic Deficit (SWEDDs) | Fullard, M.E.; Weintraub, D; Duda, J.E.; Morley, J.F. | 2015-06-14 | MDS: San Diego, CA |
| Incident Impulse Control Disorder Behaviors and Serial Dopamine Transporter Imaging in De Novo Parkinson Disease (Poster) | Smith, K; Xie, S; Weintraub, D | 2015-06-14 | MDS: San Diego, CA |
| 2015 PPMI Annual Meeting - Day 2 | PPMI Steering Committee & Cores | 2015-05-14 | PPMI Annual Meeting |
| 2015 PPMI Annual Meeting - Day 1 | PPMI Steering Committee & Cores | 2015-05-13 | PPMI Annual Meeting |
| Assessment of Parkinson disease progression using 123- I I-Ioflupane SPECT: Update from the Parkinson Progression Marker Initiative Trial | Seibyl, J; Jennings, D; Marek, K; the Parkinson's Progression Markers Initiative investigators | 2015-04-23 | AAN: Washington, DC |
| Presence of Cerebral Amyloid Modulates Phenotype & Pattern of Neurodegeneration in Early Parkinson's Disease | McMillan, C; Wolk, D | 2015-04-22 | AAN: Washington, DC |
| CSF A?1-42 predicts cognitive impairment in de novo PD patients | Terrelonge, M; Marder, K; Weintraub, D; Alcalay, R | 2015-04-22 | AAN: Washington, DC |
| Objective Measurement of Upper Extremity Motor Function in de novo Parkinson's Disease | Chahine, L; Uribe, L; Hogarth, P; Jennings, D; The Parkinson's Progression Markers Initiative | 2015-04-21 | AAN: Washington, DC |
| Identifying drug-naïve Parkinsonism with Non-motor features & CSF biomarkers: A case-control study | Jain, S; Young Park, S; Comer, D; Rudoy, D; Ivanco, L | 2015-04-21 | AAN: Washington, DC |
| Using non-motor features to define clinical and biomarker patterns of early drug-naïve Parkinsonism | Jain, S; Young Park, S; Comer, D | 2015-04-21 | AAN: Washington, DC |
| Non-motor symptoms in early drug-naïve Parkinson's disease | Liu, R; Umbach, D; Peddada, S; Xu, Z; Tröster, A; Huang, X; Chen, H | 2015-04-21 | AAN: Washington, DC |
| Early Detection of Parkinson's Disease through Shame Based Features from 123I-Iflupane Spect Imaging | Noopur A. Bhalchandra, R. Prashanth, Sumantra Dutta Roy, Santosh Noronha | 2015-04-16 | New York, USA |
| Early Detection of Parkinson's Disease Through Shape Based Features From 123I-Ioflupane SPECT Imaging | Bhalchandra, N; Prashanth, R; Roy, S; Noronha, S | 2015-04-16 | International Symposium on Biomedical Imaging: Brooklyn, NY |
| Longitudinal PD Biomarker Studies: DeNoPa and PPMI | Mollenhauer, B | 2015-03-22 | AD/PD: Nice, France |
| Progression of White Matter Degeneration in Early Parkinson's Disease: A Multicenter Evaluation Using Diffusion Tensor Imaging | Zhang, Y; Wu, K; Schuff, N; The Parkinson's Progression Markers Initiative | 2015-03-21 | AD/PD: Nice, France |
| ACCURATE, NON-INVASIVE AND COST-EFFECTIVE PREDICTIVE MODEL FOR PARKINSON'S DISEASE. | Mike A Nalls and Andrew B Singleton on behalf of the Michael J. Fox foundation's Parkinson's Progression Markers Initiative (PPMI) study, the Parkinson Associated Risk Study (PARS), the NINDS Parkinson's Disease Biomarker Program (PDBP) and the International Parkinson's Disease Genomics Consortium (IPDGC). | 2015-03-18 | AD/PD: Nice, France |
| PPMI Progress Update: Available Data and Biosamples | Ken Marek and The Michael J. Fox Foundation | 2014-12-15 | Webinar |
| Can We Reliably Establish Parkinson's Disease Subtypes In De Novo Patients: Results From The PPMI Study | Simuni, T; Caspell-Garcia, C; Coffey, C; Uribe, L; Lasch, S; Jennings, D; Tanner, C; Marek, K; The Parkinson's Progression Markers Initiative | 2014-06-12 | MDS: Stockholm, Sweden |
| Excessive Day Time Sleepiness is Not Part of Parkinson's Disease Disability in De Novo Patients: Results from the PPMI Study | Simuni, T; Caspell-Garcia, C; Coffey, C; Chahine, L.C; Lasch, S; Oertel, W; Marek, K for the PPMI Sleep Working Group; The Parkinson's Progression Markers Initiative | 2014-06-11 | MDS: Stockholm, Sweden |
| PPMI Breakfast Status Update | Ken Marek | 2014-06-10 | MDS: Stockholm, Sweden |
| Mild Cognitive Impairment and Neuropsychiatric Symptoms in Early, Untreated Parkinson Disease: Results from the PPMI Study | Weintraub, D; Simuni, T; Coffey, C; Caspell-Garcia, C; Foster, E; Barone, P; Leverenz, J; Burn, D; Eberling, J; Chahine, L; Litvan, I; Troyer, M; Siderowf, A; Aarsland, D; Hawkins, K; The PPMI Cognitive Behavioral Working Group; The Parkinson's Progression Marker Initiative | 2014-06-10 | MDS: Stockholm, Sweden |
| Multicenter Evaluation Of Parkinson's Disease Progression Using 123- I I-Ioflupane SPECT: Update From The Parkinson's Progression Marker Initiative Trial | Seibyl, J; Jennings, D; Coffey, C; Marek, K | 2014-06-09 | MDS: Stockholm, Sweden |
| The Parkinson's Progression Marker Initiative (PPMI) ? Assessment Of Clinical, Imaging And CSF PD Biomarkers | The Parkinson's Progression Markers Initiative | 2014-06-09 | MDS: Stockholm, Sweden |
| What Do We Now Know About Alpha-Synuclein's Role In Parkinson's Disease Pathology? | Trojanowski, J.Q. | 2014-06-09 | MDS: Stockholm, Sweden |
| Degeneration of Corticostriatal Fibers in Parkinson's Disease and their Differential Relations to Cognitive and Motor Deficits | Zhang, Y; Wu, K; Buckley, S; Mendick, S; Seibyl, J; Foster, E; Coffey, C; Marek, K; Schuff; N; The Parkinson's Progression Markers Initiative | 2014-06-09 | MDS: Stockholm, Sweden |
| 2014 PPMI Annual Meeting - Day 2 | PPMI Steering Committee & Cores | 2014-05-07 | PPMI Annual Meeting |
| 2014 PPMI Annual Meeting - Day 1 | PPMI Steering Committee & Cores | 2014-05-06 | PPMI Annual Meeting |
| REM Sleep And Motor Symptoms In Parkinson's Disease: A Cross Sectional Analysis | Mahajan, A; Rosenthal, L; Gamaldo, C; Salas, R. M; Pontone, G; McCoy, A; Gulyani, S; Umeh, C; Mari, Z | 2014-04-29 | AAN: Philadelphia, PA |
| AAN 2014: Differential Patterns Of White Matter Degradation In Relation To Cognitive And Motor Deficits In Parkinson's Disease | Zhang, Y; Schuff, N; the Parkinson's Progression Markers Initiative | 2014-04-29 | AAN: Philadelphia, PA |
| Neurobehavioral Disorders In Parkinsonian Patients Without Dopamine Deficits (SWEDD) | Amin Demerdash, MBBCh; Kenneth M Heilman, MD, FAAN; Joanna Myers; Chase Mitchell, BS; David Standaert, MD,PhD, FAAN; Frank Skidmore, MD | 2014-04-29 | Philadelphia, PA |
| Developing a Translational Toolbox for Parkinson disease: The Parkinson Progression Marker Initiative | Ken Marek | 2014-03-04 | Keystone Symposia's Parkinson?s Disease: Genetics, Mechanisms, and Therapeutics Conference |
| PPMI Genetics Kick-Off Meeting - Day 2 | PPMI Steering Committee & Cores | 2013-09-17 | PPMI Genetics Kick-Off Meeting |
| PPMI Genetics Kick-Off Meeting - Day 1 | PPMI Steering Committee & Cores | 2013-09-16 | PPMI Genetics Kick-Off Meeting |
| Developing a Translational Toolbox for Parkinson Disease: The Parkinson Progression Marker Initiative | Ken Marek | 2013-07-13 | Alzheimer's Imaging Consortium (AIC): Boston, MA |
| PPMI Status Update | Ken Marek | 2013-07-11 | World Wide ADNI: Boston, MA |
| Parkinson's Progression Markers Initiative (PPMI) | Trojanowski, J.Q. | 2013-06-21 | American Association of Neuropathologists (AANP): Charleston, SC |
| The Parkinson Progression Marker Initiative (PPMI) ? Baseline PD, healthy, and SWEDD data | Parkinsons Progression Marker Initiative | 2013-06-18 | MDS: Sydney, Australia |
| Cognitive performance and psychiatric symptoms in de novo, untreated Parkinson's disease: results from the PPMI study | Weintraub, D; Simuni, T; Coffey, C; Foster, E; Chahine, L; Litvan, I; Troyer, M; Siderowf, A; Hawkins, K; on behalf of the PPMI Cognitive Behavioral Working Group and PPMI Investigators | 2013-06-18 | MDS: Sydney, Australia |
| Relationship between Serum Urate and Clinical Features in Early Parkinsons Disease: PPMI Baseline Data | Constantinescu, R; Jennings, D; Foster, E.D; Auinger, P; Coffey, C.S; Marerk, K; the Parkinson's Progression Marker Initiative | 2013-06-18 | MDS: Sydney, Australia |
| PPMI Breakfast Status Update | Ken Marek | 2013-06-18 | MDS: Sydney, Australia |
| 123-I Ioflupane SPECT Measures of Parkinson Disease Progression in the Parkinson Progression Marker Initiative (PPMI) Trial | Seibyl, JP; Jennings, D; Grachev, I; Coffey, C; Marek, KL; on behalf of the PPMI Investigators | 2013-06-17 | MDS: Sydney, Australia |
| 123-I Ioflupane SPECT Measures of Parkinson Disease Progression in the Parkinson Progression Markers Initiative (PPMI) Trial | Seibyl, John; Jennings, Danna; Grachev, Igor D.; Coffey, Christopher; and Marek, Kenneth on behalf of the PPMI Investigators | 2013-06-10 | Society of Nuclear Medicine and Neuroimaging (SNMMI): Vancouver, Canada |
| 2013 PPMI Annual Meeting - Day 2 | PPMI Steering Committee & Cores | 2013-05-08 | PPMI Annual Meeting |
| 2013 PPMI Annual Meeting - Day 1 | PPMI Steering Committee & Cores | 2013-05-07 | PPMI Annual Meeting |
| The Parkinson Progression Marker Initiative (PPMI) | Ken Marek & PPMI Senior Leadership | 2013-03-23 | AAN: San Diego, CA |
| Non-motor Subtypes of Early Parkinson Disease in the Parkinson's Progression Markers Initiative | S. Jain; S Young Park | 2013-03-22 | WFN: San Diego, CA |
| Feasibility and Safety of Lumbar Punctures in the Parkinson Progression Marker Initiative (PPMI) | Samuel Frank, Boston, MA, Shirley Lasch, New Haven, CT, Chelsea Caspell, Iowa City, IA, Liz Uribe, Iowa City, IA, Danna Jennings, New Haven, CT, Kenneth Marek, New Haven, CT, Investigators of Parkinson Progression Markers Initiative, New Haven, CT | 2013-03-19 | AAN: San Diego, CA |
| Visualization and Quantification of the Striato-pallidonigral Fibers in Parkinson's Disease Using Diffusion Tensor Imaging | Yu Zhang, Katherine Wu, Shannon Buckley, Norbert Schuff | 2013-03-07 | AD/PD: Florence, Italy |
| International Conference on Alpha-Synuclein in Parkinson's Disease 2013: Parkinson's Progression Markers Initiative (PPMI) | John Q. Trojanowski, M.D., Ph.D. | 2013-03-03 | International Conference on Alpha-Synuclein in Parkinson's Disease: Dubai, UAE |
| Association between CSF biomarkers and clinical phenotype of early Parkinson's disease in the Parkinson's Progression Marker Initiative (PPMI) | Ju-Hee Kang, Chelsea Caspell, Chris Coffey, Peggy Taylor, Mark Frasier, Kenneth Marek, John Q. Trojanowski, Leslie M. Shaw, and the Parkinson's Progression Marker Initiative | 2012-06-17 | MDS: Dublin, Ireland |
| Frequency of Impulse Control Disorder Symptoms in De Novo Parkinson Disease Patients and Healthy Controls | Daniel Weintraub, Kimberly Papay, Andrew Siderowf, and the Parkinson's Progression Markers Initiative | 2012-06-17 | MDS: Dublin, Ireland |
| Baseline Neuroimaging Characteristics of the Parkinson's Progression Marker Initiative (PPMI) Parkinsons and Healthy Cohorts | J. Seibyl, MD on behalf of the PPMI Investigators | 2012-06-17 | MDS: Dublin, Ireland |
| 2012 PPMI Annual Meeting | PPMI Steering Committee & Cores | 2012-05-02 | PPMI Annual Meeting |
| Overview of PPMI | Todd Sherer, Sohini Chowdhury, Mark Frasier, Jamie Eberling, Bernard Ravina, Andrew Siderowf, Clemens Scherzer, Danna Jennings, Caroline Tanner, Karl Kieburtz, Brit Mollenhauer, John Seibyl, Christopher Coffey, Arthur Toga, Leslie Shaw, John Q. Trojanowski, and Ken Marek | 2011-05-15 | Society for Clinical Trials: Vancouver, Canada |
| 2011 PPMI Annual Meeting | PPMI Steering Committee & Cores | 2011-05-05 | PPMI Annual Meeting |
| Clinical Site Training on Biologics | Alison Ansbach, MS and Mark Frasier, PhD | 2010-11-01 | Webinar |
| PD Therapeutics Conference: Update on PPMI | Ken Marek | 2010-10-07 | PD Therapeutics Conference |
| Clinical Site Training on Cognitive Assessments | Andrew Siderowf, MD | 2010-06-25 | Webinar |
| Introduction to PPMI | M Frasier, S Chowdhury, T Sherer , J Eberling, C Meunier, B Ravina, A Siderowf, C Scherzer, D Jennings, C Tanner, K Kieburtz, C Coffey, W Poewe, B Mollenhauer, J Seibyl, A Toga, A Ansbach, P De Blasio, M Piovella, J Trojanowski, L Shaw, A Singleton, and K Marek | 2010-06-17 | MDS: Buenos Aries, Argentina |
| 2010 Investigators Meeting Slides | PPMI Steering Committee & Presenters | 2010-03-12 | PPMI Annual Meeting |
| PPMI 2017 Annual Meeting Agenda | 0000-00-00 | ||
| Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson's Disease Patients | Simon Buatois, Sylvie Retout, Nicolas Frey, Sebastian Ueckert | 0000-00-00 | |
| Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson's Disease Patients | Simon Buatois, Sylvie Retout, Nicolas Frey, Sebastian Ueckert | 0000-00-00 |
